Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 65,516 shares at $0.34 ($22K) on 2012-06-06, disclosed to the SEC on 2012-06-08.
Scheduled sale ($22k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |
| ALXA | SELL | 2009-12-18 | $100K | — | Filing → |